Actively Recruiting
DEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema.
Led by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Updated on 2024-11-15
1998
Participants Needed
2
Research Sites
565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The DEPRECAP (Early detection of lung cancer) study is an ongoing, prospective, longitudinal, multicenter lung cancer screening program that recruited individuals with COPD or emphysema from the pulmonary clinics of Fundación Jiménez Díaz University Hospital and Villalba General Hospital, in Madrid, Spain. The aim of this observational study is to determine the scientific evidence needed to study the benefit and potential effects of lung cancer screening in this group of patients and to determine the long-term effects of the intervention in reducing the high mortality rates associated with late-stage lung cancer diagnosis in a very high-risk population, to address under-diagnosis of COPD and to promote smoking cessation. This leads to the creation of a registry with clinical, radiological, functional data and biological samples for future studies in this cohort of patients to provide the scientific evidence needed to study the benefit and potential effects of screening for lung cancer and other tobacco-related pathologies diagnosed by Low-dose CT (LDCT)
CONDITIONS
Official Title
DEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Current or former smokers with less than 15 years of smoking abstinence and a cumulative smoking exposure greater than 30 pack-years
- Diagnosis of COPD according to the GOLD guidelines and/or emphysema identified by low-dose CT scan and/or a carbon monoxide diffusing capacity (DLCO) lower than 80% of predicted
- Age between 55 and 75 years
- Males or females who agree to participate and provide informed consent
You will not qualify if you...
- Recent history of cancer except non-melanoma skin cancer or carcinoma in situ
- Medical conditions posing a significant risk of death
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Fundación Jimenez Díaz Universitary Hospital
Madrid, Spain, 28040
Actively Recruiting
2
Pneumology department. Fundación Jimenez Díaz University Hospital
Madrid, Spain, 28040
Actively Recruiting
Research Team
C
Carolina Gotera, MD
CONTACT
M
María Jesús Rodríguez Nieto, MD phD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here